← BIO-TECHNE Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $499.0m |
$563.0m
+12.82%
|
$643.0m
+14.21%
|
$714.0m
+11.04%
|
$738.7m
+3.46%
|
$931.0m
+26.04%
|
$1.1b
+18.75%
|
$1.1b
+2.81%
|
$1.2b
+1.97%
|
$1.2b
+5.23%
|
$1.2b
-0.72%
|
|
| Cost of Revenue | $162.4m |
$188.5m
+16.07%
|
$210.8m
+11.88%
|
$240.5m
+14.07%
|
$255.5m
+6.23%
|
$298.2m
+16.71%
|
$349.1m
+17.08%
|
$366.9m
+5.09%
|
$389.3m
+6.12%
|
$429.4m
+10.28%
|
$424.3m
-1.17%
|
|
| Gross Profit | $336.7m |
$374.5m
+11.25%
|
$432.1m
+15.38%
|
$473.5m
+9.57%
|
$483.2m
+2.05%
|
$632.9m
+30.97%
|
$756.5m
+19.54%
|
$769.8m
+1.76%
|
$769.7m
-0.01%
|
$790.3m
+2.67%
|
$786.5m
-0.48%
|
|
| Selling, General and Administrative Expense | $140.9m | $200.4m | $240.6m | $264.4m | $260.6m | $325.0m | $372.8m | $378.4m | $466.4m | $588.5m | $362.5m | |
| Amortization of Intangible Assets | — | $44.4m | $47.1m | $58.7m | $61.1m | $64.9m | $74.1m | $77.5m | $79.9m | $76.0m | — | |
| Operating Expenses | $186.1m | $254.0m | $296.0m | $326.8m | $325.8m | $395.6m | $459.9m | $470.9m | $563.0m | $688.0m | $492.2m | |
| Operating Income (Loss) | $150.6m |
$120.6m
-19.93%
|
$136.2m
+12.93%
|
$146.7m
+7.74%
|
$157.4m
+7.29%
|
$237.3m
+50.74%
|
$296.6m
+24.99%
|
$298.9m
+0.79%
|
$206.7m
-30.86%
|
$102.3m
-50.53%
|
$294.3m
+187.81%
|
|
| Investment Income, Net | $249k | $304k | $409k | $569k | $605k | $473k | $794k | $3.4m | $3.3m | $3.9m | — | |
| Debt and Equity Securities, Realized Gain (Loss) | — | — | — | — | — | — | — | — | $300k | — | — | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | $49.3m | $283k | — | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | — | — | ($3.5m) | — | — | |
| Other Nonoperating Income (Expense) | ($1.6m) | ($1.6m) | ($447k) | ($13.6m) | $137.7m | ($75.6m) | $15.3m | $47.5m | ($8.6m) | $831k | — | |
| Interest Expense (non-operating) | $1.7m | $7.4m | $10.2m | $21.7m | $19.2m | $14.0m | $11.3m | $11.2m | $15.7m | $8.5m | $9.7m | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | — | ($1.1m) | ($6.8m) | $938k | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $120.2m | $81.7m | $81.6m | $64.1m | $245.4m | $95.7m | $255.1m | $288.5m | $174.8m | $86.8m | $147.1m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $147.5m | $112.0m | $126.0m | $112.0m | $276.5m | $148.2m | $301.4m | $338.7m | $185.7m | $98.5m | $147.1m | |
| Current Income Tax Expense (Benefit) | — | — | $45.7m | $30.0m | $33.6m | $36.6m | $31.2m | $83.0m | $57.7m | $76.2m | $37.6m | |
| Income Tax Expense (Benefit) | $43.0m | $35.9m | ($198k) | $15.9m | $47.2m | $8.6m | $38.3m | $53.2m | $17.6m | $25.1m | $37.6m | |
| Net Income (Loss) Attributable to Parent | $104.5m |
$76.1m
-27.17%
|
$126.2m
+65.80%
|
$96.1m
-23.84%
|
$229.3m
+138.67%
|
$140.4m
-38.76%
|
$272.1m
+93.75%
|
$285.3m
+4.86%
|
$168.1m
-41.07%
|
$73.4m
-56.34%
|
$109.5m
+49.18%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | $126.0m |
$96.0m
-23.86%
|
$229.1m
+138.70%
|
$140.3m
-38.74%
|
$271.9m
+93.79%
|
$285.2m
+4.88%
|
$168.1m
-41.07%
|
$73.4m
-56.35%
|
$109.5m
+49.26%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | $0 | $0 | $0 | $0 | ($825k) | ($9.0m) | $179k | — | — | $109.5m | |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | — | $108k | $105k | $224k | $86k | $121k | $70k | $33k | $37k | — | |
| Earnings Per Share, Basic | $2.81 | $2.04 | $3.36 | $2.54 | $6.00 | $3.62 | $6.93 | $1.81 | $1.07 | $0.47 | $0.71 | |
| Earnings Per Share, Diluted | $2.80 | $2.03 | $3.31 | $2.47 | $5.82 | $3.47 | $6.63 | $1.76 | $1.05 | $0.46 | $0.70 | |
| Common Stock, Dividends, Per Share, Declared | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $0.32 | $0.32 | $0.32 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 37.2m | 37.3m | 37.5m | 37.8m | 38.2m | 38.7m | 39.2m | 157.2m | 157.7m | 157.5m | 155.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | 37.3m | 37.5m | 38.1m | 38.9m | 39.4m | 40.5m | 41.0m | 161.9m | 160.8m | 159.7m | 156.9m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | — | — | — | — | — | — | ($19.1m) | ($10.0m) | $7.0m | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | ($825k) | ($9.0m) | $179k | — | — | — | |
| Reclassification from AOCI, Current Period, before Tax, Attributable to Parent | — | — | — | — | — | — | — | — | ($13.5m) | ($11.2m) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.